NCBiotech News

GreenLight Biosciences, with a growing R&D site in RTP, is the latest local company to go public using a SPAC, to accelerate its development of RNA products for human health and agriculture.

AgBiome, the fast-growing agricultural technology firm that harnesses plant microbiomes to develop novel crop protection products, has landed a whopping $116 million in funding.

Mackenzie Dixon didn't have much career direction when dropped out of high school and entered community college, but found a career opportunity as a contract process technician at Novo Nordisk in Clayton.

Thermo Fisher Scientific, a leader in North Carolina’s booming pharmaceutical contract manufacturing industry, is back in growth mode with plans to invest $154 million and create 290 more jobs at its sprawling Greenville campus.

Durham-based gene editing company Precision Biosciences has inked a deal with gene editing company iECURE to advance one of Precision’s drug candidates into Phase 1 clinical studies

On Sept. 23 and 24 NCBiotech and UNC FastTraCS, with support from NC IDEA, are sponsoring a two-day virtual conference, Accelerating Health Care Innovation in North Carolina: Charting the Course.

Alamance Community College just got a big boost to its Biotechnology Center of Excellence, a $17.4 million facility scheduled to open in the fall of 2022, with a $1.1 million equipment grant from the federal Economic Development Administration.

Quality Chemical Laboratories, a Wilmington company that provides contract chemistry services to the pharmaceutical and biotech industries, started modestly in 1998 with five employees bgut today the company has more than 250 employees and is building a new facility.

Adrian Percy, one of the world’s top leaders in the agriculture field, is set to become the first executive director of the North Carolina Plant Sciences Initiative.

The effectiveness of Morrisville-based CivaTech Oncology’s implantable radiation device as a treatment for a soft tissue cancer was highlighted recently in an article in the Journal of Surgical Research.

Jose Resto retired from his 22-year Army career on May 1 he was ready for a new challenge. On August 30, he became a full-time Pfizer employee, converting his military experience in warehouse operations into a satisfying new career opportunity.

Durham's Bioventus is adding to its run of acquisitions with a $50 million escrow payment to Israeli med tech startup CertiHeal.

Army veteran Diane Zambrano has walked a winding career path that even took her through a "Delta variant," but she's now excited to be part of North Carolilna's solid and rewarding biopharmaceutical industry.

Durham's home-grown Humacyte becomes a public company today, as it prepares for final FDA approval of its unique bioengineered human tissue replacement systems.

Jared Zimmel, a biomedical tech specialist on WakeMed’ s clinical engineering team, exemplifies the kind of entrepreneurial thinking that will be championed in a virtual conference, "Accelerating Health Care Innovation in North Carolina: Charting the Course," Sept. 23 and 24.